Also trades as: BETR.CN (CNQ) · $vol 0M
BETRF OTC
BetterLife Pharma Inc.
1W: -20.5%
1M: -7.2%
3M: +47.3%
YTD: +569.2%
1Y: +252.4%
3Y: +212.7%
5Y: -17.7%
$0.19
-0.01 (-5.02%)
Weekly Expected Move ±19.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$2M
+63.8% ▲
Net Income
-$1M
+57.5% ▲
EPS (Diluted)
$-0.01
+64.1% ▲
EBITDA
-$2M
+45.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $18K | $18K | $0 | $0 | $0 |
| Gross Profit | -$18K | -$18K | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $5M | $3M | $571K | $424K | $86K |
| SG&A Expenses | $5M | $7M | $3M | $4M | $2M |
| Operating Expenses | $10M | $9M | $3M | $5M | $2M |
| Operating Income | -$10M | -$9M | -$3M | -$5M | -$2M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $58K | $67K | $51K | $319K | $232K |
| Income Before Tax | -$12M | -$9M | -$3M | -$4M | -$2M |
| Tax Expense | $167K | $0 | $0 | $0 | $0 |
| Net Income | -$12M | -$9M | -$3M | -$4M | -$1M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.16 | $-0.10 | $-0.03 | $-0.03 | $-0.01 |
| EBITDA | -$12M | -$9M | -$3M | $0 | -$2M |
| Shares Outstanding | 75M | 87M | 109M | 124M | 146M |